2HOLSERBAUM D, HAQQI T M. Genetics and osteoarthrids. Expoxing the iceberg[J]. Arthritis Rheum, 1999,42:397-405.
3BELLAMY N, CAMPBELL J, ROBINSON V, et al. Intraarticular corticosteroid for treatment of osteoarthritis of the knee [ J ]. Cochrane Database Syst Rev, 2005, 18(2):CD005328.
4LIPIELLO L, WOODWARD J, KARPMAN R, et al. In vivo chondroprotection and metabolic synergy of glucosamine and chondroitin sulfate[J]. Clin Orthop, 2000,381:229-240.
5FELSON D T, ZHANG Y. An update on the epidemiology of knee and hip arthritis with a view to prevention[J]. Arthritis Rheum, 1998, 41 :1343 - 55.
3Nagler AC. Suppression of type II col agen-induced arthritis by intragastric administration of soluble type II col agen[J].{H}Proceedings of the National Academy of Sciences(USA),1986,(19):7443-7446.
4Vol enhoven RF. Tolerance induction by a poorly arthritogenic col agen II can prevent col agen-induced arthritis[J].Cel Immunol,1988,(01):146-155.
5Ding CH,Li Q,Xiong ZY. Oral administration of type II col agen suppresses pro-inflammatory mediator production by synoviocytes in rats with adjuvant arthritis[J].{H}CLINICAL AND EXPERIMENTAL IMMUNOLOGY,2003,(03):416-423.
6Trentham DE. Effects of oral administration of type II col agen on rheumatoid arthritis[J].{H}SCIENCE,1993,(5129):1727-1730.
7Trentham DE. New focus on treatment for rheumatoid arthritis[J].{H}Current Opinion in Rheumatology,1993,(02):178-183.
8Park KS,Park MJ,Cho ML. Type II col agen oral tolerance,mechanism and role in col agen-induced arthritis and rheumatoid arthritis[J].{H}MODERN RHEUMATOLOGY,2009,(06):581-589.
9Stancikova M,Stancik R,Gubzova Z. Col agen in the treatment of rheumatic diseases--oral tolerance[J].{H}Bratislavske Lekarske Listy,1999,(10):567-571.
